The primary function of PKC is phosphorylating targeted proteins, which in turn operating on gene expression in diabetes, thereby mediating abnormalities of blood flow and permeability via inhibiting NO production [120] or activating NF-κB [121] and microvascular matrix proteins [122] in both diabetic patients [123] and animal models [124]. This evidence concerns the gene PRRT2 and diabetes mellitus.